癌症中的Th17细胞功能:免疫抑制剂或抗瘤盟友?
Milad Taghizadeh Anvar1, Kimiya Rashidan1, Nima Arsam2
1Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Cancer cell international
|October 28, 2024
概括
辅助T17 (Th17) 细胞在癌症中起着双重作用,促进瘤生长和调解抗瘤免疫力. 了解它们的可塑性是开发向癌症治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 辅助性T细胞17 (Th17) 是免疫反应至关重要的淋巴细胞,产生介质蛋白-17 (IL-17).
- Th17细胞在瘤微环境中表现出显著的可塑性,采用不同的表型.
研究的目的:
- 阐明Th17细胞在癌症中的复杂功能.
- 审查最近关于Th17细胞可塑性和癌症中的作用的研究.
- 为设计针对Th17细胞的新型治疗策略提供信息.
主要方法:
- 在癌症中对Th17细胞的最新研究的文献综述.
- 在瘤微环境中分析Th17细胞可塑性和表型.
- 综合发现,以确定治疗点.
主要成果:
- Th17细胞具有双重作用:通过免疫抑制和血管生成促进瘤的进展,并调解抗瘤免疫力.
- Th17细胞可以转化为Th1表型,产生干扰素- (IFN-γ).
- Th17细胞的可塑性允许它们支持或抑制瘤生长.
结论:
- Th17细胞代表了癌症免疫力的双刃剑.
- 向瘤环境中的Th17细胞为更有效的癌症治疗提供了潜力.
- 对Th17细胞可塑性的进一步研究对于治疗进步至关重要.
相关概念视频
01:24T Cell Types and Functions
955
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
955
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
01:27Cytotoxic T Cells-mediated Immune Response
853
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
853
01:40Cell-mediated Immune Responses
67.4K
Overview
67.4K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K